Mechelen, Belgium

Pascale Holemans



 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pascale Holemans: Innovator in Nucleic Acid Isolation

Introduction

Pascale Holemans is a notable inventor located in Mechelen, Belgium. She has made significant strides in the field of molecular biology, particularly in the isolation of nucleic acids. Her innovative work has implications for diagnosing and analyzing various biological conditions, showcasing her contributions to the scientific community.

Latest Patents

Pascale Holemans holds one patent titled "Isolation of nucleic acids." This patent describes improved compositions and methods for processing and analyzing samples, specifically aimed at liberating nucleic acids from biological samples. The advancements proposed by Holemans allow for direct downstream processing of nucleic acids in microfluidic systems. Such compositions and methods are invaluable for diagnosing, staging, and characterizing different biological conditions.

Career Highlights

Currently, Pascale Holemans is associated with Biocartis NV, where she applies her expertise in the development of innovative diagnostic solutions. Her work focuses on enhancing the efficiency and effectiveness of nucleic acid isolation, which is a crucial step in various biochemical analyses.

Collaborations

In her career, Pascale Holemans has collaborated with several talented professionals, including Koen Van Acker and Bart Claes. These collaborations reflect a shared commitment to advancing technology in the field of molecular diagnostics.

Conclusion

Pascale Holemans' contributions to the isolation of nucleic acids underscore her role as an influential inventor in the scientific landscape. Her patent and collaborative efforts at Biocartis NV position her as a key figure in advancing diagnostic methodologies, ultimately benefiting various biological research and medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…